Innovative drug approvals

STO-REC-STATC8F9C5T1 Official
48

China · 2024

Innovative drug approvals in China stood at 48 in 2024 (State Council).

Original source
Publisher
State Council
Authority tier
T1 Official
Locator
大力支持产业创新
Retrieved
17 Sep 2026
Status
Verified

What the source says

国家药监局统计显示,2024年累计批准上市创新药48个、创新医疗器械65个。

Verbatim extraction verified: The figure 48 is directly attested in the quoted passage (大力支持产业创新).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
State Council of China. (2024). 全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网. Retrieved September 17, 2026, from https://www.gov.cn/zhengce/202501/content_6997982.htm. Via StatOrigin, https://statorigin.org/stat/stat_C8F9C5Q0MY85N20BPY0TA0T7SQ
MLA
State Council of China. "全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网." 2024, https://www.gov.cn/zhengce/202501/content_6997982.htm. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_C8F9C5Q0MY85N20BPY0TA0T7SQ.
Chicago
State Council of China. "全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网." 2024. https://www.gov.cn/zhengce/202501/content_6997982.htm. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_C8F9C5Q0MY85N20BPY0TA0T7SQ.
BibTeX
@misc{statecouncil2024innovativea0t7sq, author = {{State Council of China}}, title = {全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市\_政策解读\_中国政府网}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_C8F9C5Q0MY85N20BPY0TA0T7SQ}, note = {Original source: https://www.gov.cn/zhengce/202501/content\_6997982.htm. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STATC8F9C5 T1 Official

Primary Source

Publisher
State Council of China · homepage ↗
Authority tier
Tier 1 · Multilateral Official
Report
全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网
Type
Press release
Published
Locator
大力支持产业创新
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_C8F9C5Q0MY85N20BPY0TA0T7SQ